BTIG Reiterates Buy Rating on Ideaya Biosciences (IDYA)
Tweet Send to a Friend
BTIG analyst Justin Zelin reiterated a Buy rating and $62.00 price target on Ideaya Biosciences (NASDAQ: IDYA).The analyst commented: "IDYA ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
